Use of central cannabinoid receptor antagonists for regulating appetence
US6344474B1 · kind B1 · utility
82Cited by
2References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 19, 1999 |
| Grant date | Feb 5, 2002 |
| Priority date | — |
| Expiry date | Aug 19, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of a central cannabinoid receptor antagonist, by itself or in association with a compound for regulating metabolic disorders, especially a &bgr;3-adrenergic receptor agonist, for the preparation of drugs useful in the treatment of appetency disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.